Skedsmo Medisinske Senter A.S.
Skedsmokorset, Norway
Medical clinic in Skedsmokorset
Presthagaveien 20, 2020 Skedsmokorset
About Skedsmo Medisinske Senter A.S.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Skedsmo Medisinske Senter A.S.
During the past decade, Skedsmo Medisinske Senter A.S. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
2006-01-01
2013-03-01
Completed
683
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study
2009-05-01
2011-08-01
Completed
178
Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B
2011-04-01
2015-07-01
Completed
751
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
2012-06-06
2021-02-01
Completed
752
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
2013-01-07
2022-05-13
Completed
559
Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
2013-07-01
2015-09-01
Completed
53
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Skedsmo Medisinske Senter A.S.
According to Clinical.Site data, the most researched conditions in "Skedsmo Medisinske Senter A.S." are
"Dyslipidemia" (3 trials), "Hypercholesterolemia" (2 trials), "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease" (1 trials) and "Diabetic Kidney Disease" (1 trials). Many other conditions were trialed in "Skedsmo Medisinske Senter A.S." in a lesser frequency.
Clinical Trials Intervention Types at Skedsmo Medisinske Senter A.S.
Most popular intervention types in "Skedsmo Medisinske Senter A.S." are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Pitavastatin" (3 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Skedsmo Medisinske Senter A.S.
The vast majority of trials in "Skedsmo Medisinske Senter A.S." are
5 trials for "All" genders.
Clinical Trials Status at Skedsmo Medisinske Senter A.S.
Currently, there are NaN active trials in "Skedsmo Medisinske Senter A.S.".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Skedsmo Medisinske Senter A.S.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Skedsmo Medisinske Senter A.S., 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".